With advanced oncology infrastructure, Bukit Tinggi Medical Centre offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2016, the MSQH accredited hospital is located in Kuala Lumpur, Malaysia, and has 171 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.